AngioDynamics (ANGO) Rating Increased to Hold at BidaskClub

AngioDynamics (NASDAQ:ANGO) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

Other equities research analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of AngioDynamics from a “buy” rating to a “hold” rating in a research report on Friday, January 26th. Craig Hallum cut shares of AngioDynamics from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Finally, TheStreet cut shares of AngioDynamics from a “b-” rating to a “c” rating in a research report on Tuesday, January 2nd. Six equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $18.60.

Shares of AngioDynamics (ANGO) opened at $16.84 on Thursday. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.56 and a quick ratio of 1.65. AngioDynamics has a 1 year low of $14.80 and a 1 year high of $18.85. The company has a market cap of $607.77, a PE ratio of -80.19, a price-to-earnings-growth ratio of 1.53 and a beta of 0.98.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings results on Thursday, January 4th. The medical instruments supplier reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. AngioDynamics had a negative net margin of 2.27% and a positive return on equity of 4.63%. The firm had revenue of $86.70 million for the quarter, compared to analysts’ expectations of $88.15 million. During the same period in the previous year, the business earned $0.19 earnings per share. AngioDynamics’s revenue for the quarter was down 2.6% compared to the same quarter last year. equities analysts anticipate that AngioDynamics will post 0.72 EPS for the current year.

Institutional investors have recently modified their holdings of the business. SG Americas Securities LLC acquired a new stake in AngioDynamics during the 3rd quarter worth about $143,000. Crossmark Global Holdings Inc. acquired a new stake in AngioDynamics during the 4th quarter worth about $172,000. Trexquant Investment LP acquired a new stake in AngioDynamics during the 3rd quarter worth about $175,000. Teachers Retirement System of The State of Kentucky raised its holdings in AngioDynamics by 54.9% during the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 11,000 shares of the medical instruments supplier’s stock worth $178,000 after buying an additional 3,900 shares during the period. Finally, Teacher Retirement System of Texas acquired a new stake in AngioDynamics during the 4th quarter worth about $201,000. Hedge funds and other institutional investors own 99.63% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “AngioDynamics (ANGO) Rating Increased to Hold at BidaskClub” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://stocknewstimes.com/2018/02/22/angiodynamics-ango-rating-increased-to-hold-at-bidaskclub.html.

AngioDynamics Company Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Analyst Recommendations for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply